For example, some genes, such as receptor tyrosine kinases (FLT3 and KIT) and RAS pathway genes, have a higher proportion of mutations in AML, whereas mutations in splicing factors (SF) and epigenetic regulators, among others, are more prevalent in MDS (20). Here, NTRK1 is linked to acute myeloid leukemia.